C. Surcel

797 total citations
48 papers, 393 citations indexed

About

C. Surcel is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, C. Surcel has authored 48 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 19 papers in Surgery and 15 papers in Rheumatology. Recurrent topics in C. Surcel's work include Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (16 papers) and Urologic and reproductive health conditions (10 papers). C. Surcel is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (16 papers) and Urologic and reproductive health conditions (10 papers). C. Surcel collaborates with scholars based in Romania, Germany and Italy. C. Surcel's co-authors include Piet Ost, Guillaume Ploussard, Alberto Briganti, Massimo Valério, Igor Tsaur, Pieter De Visschere, Giorgio Gandaglia, Isabel Heidegger, Hendrik Borgmann and Derya Tilki and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Urology and Urology.

In The Last Decade

C. Surcel

41 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Surcel Romania 12 279 115 89 83 57 48 393
M. Peyromaure France 11 371 1.3× 147 1.3× 122 1.4× 94 1.1× 48 0.8× 44 480
Neophytos Petrides United Kingdom 5 379 1.4× 92 0.8× 102 1.1× 92 1.1× 65 1.1× 9 455
Gabriele Sorce Italy 10 334 1.2× 99 0.9× 160 1.8× 80 1.0× 42 0.7× 63 445
Sacha Wolf United States 4 442 1.6× 66 0.6× 151 1.7× 47 0.6× 80 1.4× 6 475
Ahmed Elshafei United States 12 426 1.5× 150 1.3× 116 1.3× 30 0.4× 39 0.7× 49 502
Christopher J. Welty United States 9 326 1.2× 93 0.8× 137 1.5× 25 0.3× 80 1.4× 16 420
Jonathan Olivier France 12 369 1.3× 111 1.0× 47 0.5× 115 1.4× 37 0.6× 49 426
Haluk Özen Türkiye 16 492 1.8× 186 1.6× 186 2.1× 66 0.8× 76 1.3× 45 623
Ross Snow Australia 9 279 1.0× 59 0.5× 92 1.0× 43 0.5× 46 0.8× 13 343
Gyoergy Kovács Germany 8 413 1.5× 49 0.4× 102 1.1× 63 0.8× 59 1.0× 13 570

Countries citing papers authored by C. Surcel

Since Specialization
Citations

This map shows the geographic impact of C. Surcel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Surcel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Surcel more than expected).

Fields of papers citing papers by C. Surcel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Surcel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Surcel. The network helps show where C. Surcel may publish in the future.

Co-authorship network of co-authors of C. Surcel

This figure shows the co-authorship network connecting the top 25 collaborators of C. Surcel. A scholar is included among the top collaborators of C. Surcel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Surcel. C. Surcel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Surcel, C., Asıf Muneer, Anita C. Thomas, et al.. (2025). Evaluating the role of adjuvant therapy in improving outcomes for patients with lymph node-positive penile cancer following surgical management. Urologic Oncology Seminars and Original Investigations. 43(9). 485–497.
2.
Amend, Bastian, et al.. (2024). Management of acquired prostatic fistulas in adults. International Urology and Nephrology. 56(12). 3751–3757.
3.
Spiess, Philippe E., et al.. (2024). Brachytherapy and external beam radiation in the management of primary penile cancer – Game changer for organ preservation?. Cancer Treatment Reviews. 129. 102800–102800. 1 indexed citations
4.
Tsaur, Igor, et al.. (2023). Triple therapy in metastatic hormone-sensitive prostate cancer. Current Opinion in Urology. 33(6). 452–457. 1 indexed citations
5.
Tsaur, Igor, Roman A. Blaheta, Robert Dotzauer, et al.. (2022). Focal therapy for primary tumor and metastases in de novo or recurrent oligometastatic prostate cancer: current standing and future perspectives. World Journal of Urology. 41(8). 2077–2090. 2 indexed citations
6.
Surcel, C., et al.. (2021). Recent Insights on Genetic Testing in Primary Prostate Cancer. Molecular Diagnosis & Therapy. 25(4). 425–438. 1 indexed citations
7.
Kretschmer, Alexander, Guillaume Ploussard, Isabel Heidegger, et al.. (2020). Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review. European Urology Focus. 7(4). 742–751. 25 indexed citations
8.
Surcel, C., Igor Tsaur, Hendrik Borgmann, et al.. (2020). Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer. World Journal of Urology. 39(7). 2483–2490. 3 indexed citations
9.
Tsaur, Igor, Isabel Heidegger, Alexander Kretschmer, et al.. (2018). Combining anticancer drugs with osteoprotective agents in prostate cancer—A contemporary update. Urologic Oncology Seminars and Original Investigations. 36(11). 488–497. 1 indexed citations
10.
Mulders, Peter F.A., Luis Martínez‐Piñeiro, Axel Heidenreich, et al.. (2018). Adjuvant recMAGE-A3 Immunotherapy After Cystectomy for Muscle-invasive Bladder Cancer: Lessons Learned from the Phase 2 MAGNOLIA Clinical Trial. European Urology Focus. 5(5). 849–852. 3 indexed citations
11.
Ploussard, Guillaume, Giorgio Gandaglia, Hendrik Borgmann, et al.. (2018). Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review. European Urology. 76(4). 493–504. 85 indexed citations
12.
Fütterer, Jurgen J., C. Surcel, Roderick van den Bergh, et al.. (2018). Imaging modalities in synchronous oligometastatic prostate cancer. World Journal of Urology. 37(12). 2573–2583. 15 indexed citations
13.
Bağcıoğlu, Murat, C. Surcel, Serkan Özcan, et al.. (2017). Medical management in locally advanced and metastatic prostate cancer: Does changes in treatment policy have any specific effect on PSA levels?. Archivio Italiano di Urologia e Andrologia. 89(4). 282–282. 4 indexed citations
14.
Visschere, Pieter J. L. De, Alberto Briganti, Jurgen J. Fütterer, et al.. (2016). Role of multiparametric magnetic resonance imaging in early detection of prostate cancer. Insights into Imaging. 7(2). 205–214. 43 indexed citations
15.
Tsikkinis, Alexandros, Nikola Čihorić, Gianluca Giannarini, et al.. (2015). Clinical Perspectives from Randomized Phase 3 Trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database. European Urology Focus. 1(2). 173–184. 11 indexed citations
16.
Surcel, C., Prasanna Sooriakumaran, Alberto Briganti, et al.. (2014). Preferences in the management of high‐risk prostate cancer among urologists in E urope: results of a web‐based survey. British Journal of Urology. 115(4). 571–579. 22 indexed citations
17.
Surcel, C., Inge M. van Oort, Prasanna Sooriakumaran, et al.. (2014). Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review. Urologic Oncology Seminars and Original Investigations. 33(6). 265.e1–265.e7. 14 indexed citations
18.
Constantinescu, Ileana, et al.. (2012). Cytotoxic antibodies monitoring in kidney transplantation--their clinical relevance and challenges.. PubMed. 53(3). 515–9. 3 indexed citations
19.
Surcel, C., et al.. (2012). Atypical primary tuberculosis mimicking an advanced penile cancer. Can we rely on preoperative assessment?. PubMed. 53(4). 1103–6. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Peyromaure Breakdown of academic impact, for papers by Neophytos Petrides Breakdown of academic impact, for papers by Gabriele Sorce Breakdown of academic impact, for papers by Sacha Wolf Breakdown of academic impact, for papers by Ahmed Elshafei Breakdown of academic impact, for papers by Christopher J. Welty Breakdown of academic impact, for papers by Jonathan Olivier Breakdown of academic impact, for papers by Haluk Özen Breakdown of academic impact, for papers by Ross Snow Breakdown of academic impact, for papers by Gyoergy Kovács
Rankless by CCL
2026